Original Research

Published on 18 Aug 2022

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis

in Cancer Immunity and Immunotherapy

Chengyu Bian
Xinti Sun
Jingjing Huang
Wenhao Zhang
Guang Mu
Ke Wei
Liang Chen
Yang Xia
Jun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.950783

2,882 views
3 citations

Original Research

Published on 18 Aug 2022

Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma

in Cancer Immunity and Immunotherapy

Shanshan Li
Tingzhi Liu
Hailing Liu
Xiaohui Zhai
Taiyuan Cao
Hongen Yu
Wanjia Hong
Xiaoru Lin
Ming Li
Yan Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.976762

2,760 views

Review

Published on 18 Aug 2022

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?

in Cancer Immunity and Immunotherapy

Catharina Muylaert
Lien Ann Van Hemelrijck
Anke Maes
Kim De Veirman
Eline Menu
Karin Vanderkerken
Elke De Bruyne

Frontiers in Oncology

doi 10.3389/fonc.2022.979569

6,093 views
8 citations

Review

Published on 17 Aug 2022

Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Ofek Mussafi
Jie Mei
Wenjun Mao
Yuan Wan

Frontiers in Oncology

doi 10.3389/fonc.2022.948405

4,114 views
7 citations

Original Research

Published on 16 Aug 2022

Autophagy-related prognostic signature characterizes tumor microenvironment and predicts response to ferroptosis in gastric cancer

in Cancer Immunity and Immunotherapy

Haoran Li
Bing Xu
Jing Du
Yunyi Wu
Fangchun Shao
Yan Gao
Ping Zhang
Junyu Zhou
Xiangmin Tong
Ying Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.959337

3,633 views
8 citations

Correction

Published on 15 Aug 2022

Corrigendum: Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities

in Cancer Immunity and Immunotherapy

Chiara Caprioli
Iman Nazari
Sara Milovanovic
Pier Giuseppe Pelicci

Frontiers in Oncology

doi 10.3389/fonc.2022.974476

899 views
1 citation

Original Research

Published on 12 Aug 2022

Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling

in Cancer Immunity and Immunotherapy

Jin Wang
Yi Hu
Habib Hamidi
Cedric Dos Santos
Jingyu Zhang
Elizabeth Punnoose
Wenjin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.948548

3,604 views
5 citations

Case Report

Published on 11 Aug 2022

Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review

in Cancer Immunity and Immunotherapy

Dandan Geng
Yingnan Wang
Xin Zhang
Chenguang Zhao
Yao Fan
Chang Liu
Jinmei Wei
Bingjie Huo
Yang Zhao
Fengbin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.981084

3,900 views
2 citations

Mini Review

Published on 11 Aug 2022

The role of B cells in cancer development

in Cancer Immunity and Immunotherapy

Rongying Tan
Manhua Nie
Wang Long

Frontiers in Oncology

doi 10.3389/fonc.2022.958756

9,813 views
21 citations

Review

Published on 08 Aug 2022

Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Lin Zhang
Chao Zhou
Songou Zhang
Xiaozhen Chen
Jian Liu
Fangming Xu
Wenqing Liang

Frontiers in Oncology

doi 10.3389/fonc.2022.939249

4,379 views
13 citations

Original Research

Published on 05 Aug 2022

Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Juzheng Yuan
Yang Wang
Xudan Wang
Wenjie Zhang
Rui Ding
Shuqiang Yue
Xiao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.924059

2,508 views
1 citation

Original Research

Published on 04 Aug 2022

A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma

in Cancer Immunity and Immunotherapy

Sheng Yang
Jiahui Zhou
Zhihao Chen
Qingyang Sun
Dongsheng Zhang
Yifei Feng
Xiaowei Wang
Yueming Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.934928

4,498 views
18 citations

Original Research

Published on 04 Aug 2022

Bevacizumab combined with re-irradiation in recurrent glioblastoma

in Cancer Immunity and Immunotherapy

Lei She
Lin Su
Chao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.961014

3,842 views
7 citations

Systematic Review

Published on 03 Aug 2022

Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Zijun Zhao
Jin Bian
Junwei Zhang
Ting Zhang
Xin Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.843707

3,036 views
12 citations

Original Research

Published on 03 Aug 2022

Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma

in Cancer Immunity and Immunotherapy

Shui-Qing Bi
Qing-Mei Zhang
Xia Zeng
Chang Liu
Wei-Xia Nong
Huan Xie
Feng Li
Li-Na Lin
Bin Luo
Ying-Ying Ge

Frontiers in Oncology

doi 10.3389/fonc.2022.873639

2,297 views
4 citations

Original Research

Published on 02 Aug 2022

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers

in Cancer Immunity and Immunotherapy

Yuan Cai
Qingchun He
Wei Liu
Qiuju Liang
Bi Peng
Jianbo Li
Wenqin Zhang
Fanhua Kang
Qianhui Hong
Yuanliang Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.952129

8,732 views
48 citations

Navigation group

Articles

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis

Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?

Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer

Autophagy-related prognostic signature characterizes tumor microenvironment and predicts response to ferroptosis in gastric cancer

Corrigendum: Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities

Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling

Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review

The role of B cells in cancer development

Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors

Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma

A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma

Bevacizumab combined with re-irradiation in recurrent glioblastoma

Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis

Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers